Aim To determine the relationship between brain-derived neurotrophic factor (BDNF) levels and the severity of melasma. Methods This cross-sectional analytic study included consecutive patients from the Dermatology and Venereology Polyclinic at Prof. dr. Chairuddin Panusunan Lubis Universitas Sumatera Utara (Prof. dr. CPL USU) Hospital Medan from May to December 2022. Serum BDNF levels and the severity of melasma were analysed using the Kruskal-Wallis test. Results Of the total of 30 patients enrolled in the study, the majority were in the age group of 36–45 (average of 44) years and work as housewives. The highest risk factor was sun exposure. The melasma pattern was dominated by centrofacial patterns, majority of melasma types were epidermal, and the most severe degree was moderate. A moderate negative correlation between BDNF levels and the duration of melasma was found (p=0.007; r= -0.485). There was no significant relationship between BDNF levels and the severity of melasma (p=0.387). Conclusion No significant relationship between BDNF levels and the severity of melasma indicates that the causes of melasma are multifactorial, such as sun exposure, genetic, hormonal, and other factors (drugs, neural and psychological, and lipid metabolism).
Rodrigues M, In PAGH, Kang S, Amagai M, Bruckner AL, Enk AH, et al. Orringer JS. In: Fitzpatricks’s Dermatology in General Medicine. 2019.
2.
Rigopoulos D, Gregoriou S, Katsambas A. Hyperpigmentation and melasma. J Cosm Dermatol. 2007;6:195–202.
3.
Pichardo R, Vallejos Q, Feldman S, MR V, A Q, SA A, et al. The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. Int J of Dermatol. 2009;48:22–6.
4.
Sheth VM, Pandya AG. Melasma: A comprehensive update part 1. J Am Acad Dermatol. 2011;65:689–97.
5.
Murniastuti DS, Etnawati K, Pudjiati. The correlation between severity of melasma with facial wrinkles in Yogyakarta, Indonesia. Dermatology Reports. 2020;12:40–2.
6.
Rajanala S, Maymone MBC, Vashi NA. Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies. Dermatol Online J. 2019;25:1–6.
7.
Handel AC, Lima PB, Tonolli VM, Miot LDB, Miot HA. Risk factors for facial melasma in women. British Journal of Dermatology. 2014;171:588–94.
8.
Russo-Neustadt A, Chen MJ. Brain-derived neurotrophic factor and antidepressant activity. Curr Pharm Des. 2005;11:1495–510.
9.
Duman RS. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med. 2004;5:11–25.
10.
Kunugi H, Hori H, Adachi N, Numakawa T. Interface between hypothalamic – pituitary – adrenal axis and brain – derived neurotrophic factor in depression. Psychiatry Clin Neurosci. 2010;64:447–59.
11.
Botchkarev VA, Yaar M, Peters AMJ, Raychaudhuri SP, Botchkareva NV. Neurotrophis in skin biology and pathology. J Invest Dermatol. 2006;126:1719–27.
12.
Bulur I, Erdogan HK, Ciftci E, Canaz F, Yigitaslan S, Yildiz P, et al. Evaluating the role of neurotrophins in the psoriasis and metabolic syndrome relationship. Turk J Dermatol. 2017;11:168–73.
13.
Yanik ME, Erfan G, Albayrak Y, Aydin M, Kulac M, Kuloglu M. Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo. Neuropsychiatr Dis Treat. 2014;10:2361–7.
14.
Libman-Sokolowska M, Drozdowicz E, Nasierowski T. BDNF as a biomarker in the course and treatment of schizophrenia. Psychiatr Pol. 2015;49:1149–58.
15.
Zulfa RA, Putra IB, Jusuf NK. Dermoscopic imaging of melasma on various skin colors. BMJ. 2022;11:676–9.
16.
Pramedisca MA. Hubungan riwayat penggunaan kontrasepsi hormonal dengan derajat melasma [Skripsi] (Correlation between history of hormonal contraceptive use and degree of melasma. In: Indonesian. 2021.
17.
Kim JC, Park TJ, Kang HY. Skin-aging pigmentation: who is the real enemy? Cells. 2022;11(2541).
18.
Rambe PS, Simanungkalit R, Yosi A. Hubungan kadar zink serum dengan derajat keparahan melasma [Thesis] (Relationship between serum zinc levels and melasma severity. In: Indonesian. 2019.
19.
Fajriah L. Hubungan perilaku penggunaan tabir surya dengan derajat keparahan melasma [Skripsi] (Correlation between sunscreen usage behavior and melasma severity. In: Indonesian. 2021.
20.
Novarina RM, Sukanto H. Gambaran Dermoskopi dan Lampu Wood pada Melasma (The Description of Dermoscopy and Wood’s Lamp on Melasma. In: Indonesian] Berk Ilmu Kesehat Kulit Kelamin 2017. p. 8–15.
21.
Suryaningsih BE. Melasma dalam sudut pandang genetik (Melasma from a genetic perspective. In: Indonesian] MDVI. 2019. p. 162–6.
22.
Tamarina FA, Sawitri S, H. Penurunan skor melasma area and severity index (masi) antara asam traneksamat topikal dan modifikasi formula kligman dengan plasebo topikal dan modifikasi formula kligman pada pasien (Decrease in melasma area and severity index (masi) scores between topical tranexamic acid and modification of kligman’s formula with topical placebo and modification of kligman’s formula in patients. Indonesian] Berkala Ilmu Kesehatan Kulit dan Kelamin. 2018;30:231–9.
23.
Rosalina M, Jusuf NK, Putra IB. Hubungan kadar superoxidedismutase plasma dengan derajat keparahan melasma [Thesis] (Relationship between plasma superoxidedismutase levels and melasma severity. In: Indonesian. 2020.
24.
Salim YF, Yenny SW, Lestari S. Insidens melasma di poliklinik kulit dan kelamin rsup dr. M. Djamil padang tahun 2012-2015 (Melasma incidence in dermatology and venereology polyclinic dr. M.
25.
Stephanie A, Rusyati LMM, NLPRV K, Winaya KK, Suryawati N, IGAAD K. Kadar ferritin yang rendah merupakan faktor risiko melasma pada wanita (Low ferritin levels are a risk factor for melasma in women. 2022;13:487–92.
26.
Tursina D, Hajar S, Inggriyani CG. Hubungan derajat keparahan melasma dengan kualitas hidup pada pasien melasma di praktek swasta dokter spesialis kulit dan kelamin di kota banda aceh (Correlation between melasma severity degree and quality of life in melasma patients in private practice of dermatologist and venereologist in banda aceh city. Indonesian] Jurnal Ilmiah Mahasiswa Medisia. 2017;2:18–23.
27.
Raap U, Kapp A. Neurotrophins in healthy and diseased skin. G Ital Dermatol Venereol. 2010;145:205–11.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
